CareDx Stock News

Q4 2019 CareDx Inc Earnings Call

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CareDx (CDNA), ObsEva SA (OBSV) and Axsome Therapeutics

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CareDx ( CDNA – Research Report ), ObsEva SA ( OBSV – Research Report ) and Axsome Therapeutics ( A

CareDx, Inc. (CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant pat

CareDx Congratulates Johns Hopkins on Successful Follow-Up Using AlloSure of First Retransplant Patient After Immunotherapy

Shares of CareDx Inc (NASDAQ:CDNA) reached a new 52-week low on Wednesday following insider selling activity. The stock traded as low as $13.04 and last traded at $13.34, with a volume of 437311 share

CareDx, Inc. (CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant pat

CareDx Congratulates Johns Hopkins on Successful Follow-Up Using AlloSure of First Retransplant Patient After Immunotherapy

Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced that, effective immediately, it has appointed Christine M. Cournoyer, who most recently served as the

ArrowMark Colorado Holdings LLC raised its holdings in shares of CareDx Inc (NASDAQ:CDNA) by 17.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novus Therapeutics (NVUS) and CareDx (CDNA) with bullish

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novus Therapeutics

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …